Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Covista Inc. held its 2026 Annual Meeting of Shareholders on November 11, 2026, where shareholders elected eleven directors and approved the 2026 Equity Incentive Plan. Additionally, the company announced committee assignments for newly appointed independent directors Emily Chiu and Leslie Storms and reconstituted its five standing board committees.
Invesco Mortgage Capital Inc. declared a monthly cash dividend of $0.12 per share of common stock for November 2026, payable on December 14, 2026. The company also provided a monthly financial update reporting an estimated book value of $7.01 per common share and a total investment portfolio of $8.1 billion as of October 31, 2026.
Genprex, Inc. reported a net loss of $13.1 million for the nine months ended September 30, 2026, compared to $12.4 million in the prior year period. The company significantly strengthened its cash position to $15.3 million through $18.7 million in net proceeds from common stock issuances, supporting its ongoing clinical development of gene therapies for oncology and diabetes.
Liberty Latin America Md, CAO Brian D. Zook Sells $275K of Stock
Brian D. Zook, Md, CAO, sold 27,611 shares of Liberty Latin America Ltd. at $9.94 to $9.97 a share (average $9.95) in 2 transactions, worth $275K in total on Nov 11, 2026. Shares held after the trade: 14,760 (-55.5%).
Urban One reported a net loss of $119.2 million for the quarter ended September 30, 2026, primarily driven by a $128.9 million impairment charge. Net revenue decreased to $88.0 million from $92.7 million in the prior year period, while the company completed the acquisition of Service Broadcasting Group during the quarter.
Pyxis Oncology stockholders approved an amendment to the company's Certificate of Incorporation to double the number of authorized shares of common stock from 190 million to 380 million. The amendment became effective upon filing with the Secretary of State of Delaware on November 13, 2026. No shares were issued or sold as part of this filing, which primarily serves to reserve capacity for future corporate purposes.
Adient plc identifies significant risks related to the adoption of AI, evolving automotive trends like autonomous vehicles, and increasing sustainability reporting requirements. The company also highlights potential financial impacts from warranty claims, product recalls, and global tax audits.
Natural Alternatives International reported a significant decline in net sales to $28.1 million for the quarter ended September 30, 2026, compared to $37.7 million in the prior year. The company experienced a net loss of $2.5 million and noted a 'going concern' risk due to non-compliance with credit agreement covenants and the acceleration of its mortgage note payable.
Oncolytics Biotech Inc. reported a net loss of $28.4 million for the nine months ended September 30, 2026, compared to $19.9 million in the prior year period, driven by increased R&D and G&A expenses. The company's cash position decreased to $2.4 million, leading management to issue a going concern warning as existing resources are insufficient to fund operations for the next twelve months.
Gaxos.ai reported Q3 2026 financial results featuring record consolidated revenue of $2.81 million, a 464.9% increase year-over-year. The company highlighted improved operational efficiency, with revenue per dollar of advertising expense increasing 38% sequentially to $1.08. As of September 30, 2026, the company maintained a cash position of approximately $13.30 million.
Term
Q3 2026
“Our third quarter results show continued revenue growth alongside lower advertising and marketing expense. We achieved record consolidated revenue while improving revenue per dollar of advertising and marketing expense by approximately 38% from the second quarter. We remain focused on improving customer acquisition efficiency and scaling products and channels with favorable contribution economics.”
Vadim Mats, CEO of Gaxos
“We are continuously fine-tuning our approach to customer acquisition. Our revenue generated per advertising dollar showed significant improvement as we work on strategy As always, we strive to continue building on our progress.”
Advanced Micro Devices Insider Nora Denzel Sells $5.08M of Stock
Nora Denzel sold 9,000 shares of Advanced Micro Devices Inc at $564.88 a share, worth $5.08M in total on Nov 11, 2026. Shares held after the trade: 78,173 (-10.3%).
FiEE, Inc. reported its third quarter 2026 financial results, highlighted by a significant revenue surge of 382.1% to $9.6 million for the first nine months of the year. The company achieved a profit turnaround with net income of $3.6 million for the nine-month period, driven by a strategic shift from legacy hardware to AI-integrated SaaS and digital art advisory services.
Term
Q3 2026
“We delivered solid financial results during the period and made meaningful progress in building a more diversified, scalable digital services platform.”
Rafael Li, Chief Executive Officer and President of FiEE
CO2 Energy Transition Corp. reported net income of $680,745 for the nine months ended September 30, 2026, primarily driven by $1.58 million in interest earned on trust account investments. During the period, the company experienced significant redemptions, with common stock subject to possible redemption decreasing from 6,900,000 shares to 1,030,715 shares.
Churchill Capital Corp XII is a shell company that completed its IPO on April 29, 2026, raising $414 million held in a Trust Account for a future business combination. As of September 30, 2026, the company has 41,750,000 Class A and 13,800,000 Class B ordinary shares outstanding and is classified as an emerging growth company.
ARMOUR Residential REIT filed a formal investor presentation providing a monthly update on its financial position and portfolio composition as of October 31, 2026. The filing includes detailed data on its $21.1 billion mortgage-backed securities portfolio, leverage ratios, and liquidity position, as well as confirmation of its November 2026 common dividend of $0.24 per share.
Haemonetics VP, CAO Farris Maryanne Maunsell Sells $101K of Stock
Farris Maryanne Maunsell, VP, CAO, sold 836 shares of Haemonetics Corp at $120.99 a share, worth $101K in total on Nov 11, 2026. Shares held after the trade: 5,828 (-12.5%).
Xerox Holdings $121M Debt Financing with Consenting Holders
Xerox completed a debt exchange where holders of $173.7 million in 5.500% Senior Notes due 2028 swapped their holdings for $121.1 million in new 10.250% Senior Secured First Lien Notes due 2030 and 3.87 million shares of common stock. The new notes are secured by substantially all assets of Xerox and its subsidiaries on a senior basis.
Churchill Capital Corp XIII is a shell company that completed its initial public offering on August 3, 2026, raising $414,000,000 held in a U.S.-based trust account. As of September 30, 2026, the company is in its search phase for an initial business combination and has until at least August 3, 2028, to consummate a transaction.
Forge Nano reported total net sales of $6.07 million for the nine months ended September 30, 2026, a 14% increase year-over-year, though it faced a significant gross loss of $5.04 million. The company's net loss widened to $44.5 million for the period, driven by increased operating expenses and an $11.2 million nonoperating expense related to debt and warrant fair value changes.
Enveric Biosciences reported a net loss of $7.21 million for the nine months ended September 30, 2026, compared to $6.58 million in the prior year period, driven by increased research and development costs. The company strengthened its cash position to $5.61 million through various financing activities, including private placements and warrant exercises, resulting in a total shareholders' equity of $5.73 million.
Empire Petroleum reported a net loss of $12.0 million for the nine months ended September 30, 2026, compared to a $13.1 million loss in the prior year period. While total product revenues increased to $29.2 million, the company's bottom line was impacted by a $5.0 million loss on derivatives and significant operating expenses.
Aaron D. Wade, Executive Vice President and Chief Investment Officer, will depart Onity Group Inc. on December 31, 2026. Richard J. Bradfield, currently EVP and former Chief Growth Officer, will assume the role of Chief Investment Officer. Mr. Wade will receive severance benefits and a 2026 annual cash incentive with a target value of $490,356.
Auddia Inc. reported a net loss of $7.37 million for the nine months ended September 30, 2026, compared to a $5.70 million loss in the prior year period. While the company began generating modest revenue of $22,268, operating expenses increased significantly due to higher sales, marketing, and transaction costs related to a proposed merger with Thramann Holdings.
CONX Corp. announced that its financial statements for the fiscal year ended December 31, 2024, should no longer be relied upon due to an error in the consolidated statement of cash flows. The error involved the incorrect classification of interest income on cash equivalents, and correcting it will shift approximately $5.9 million from investing activities to operating activities. The restatement has no impact on the company's net income, total assets, or cash position.
FutureFuel Insider Donald C. Bedell Buys $113K of Stock
Donald C. Bedell bought 40,000 shares of FutureFuel Corp. at $2.83 a share, worth $113K in total on Nov 12, 2026. Shares held after the trade: 50,000 (+400.0%).
Apple Hospitality REIT, Inc. made available an updated investor presentation on its website for use at various upcoming conferences and meetings. The presentation includes operating statistics for October and November 2026 and provides an overview of the company's hotel portfolio and operating strategy.
WhiteHawk Minerals Corp. reported a net loss of $33.4 million for the nine months ended September 30, 2026, primarily driven by a $21.7 million loss on debt extinguishment and increased management fees. Despite the year-to-date loss, the company achieved a net income of $6.9 million in the third quarter of 2026, supported by $17.0 million in royalty revenue and a $3.2 million gain on commodity derivatives.
URSB Bancorp, Inc. reported net income of $653 thousand for the nine months ended September 30, 2026, compared to $327 thousand in the prior year period. The company completed its initial public offering during the first quarter of 2026, significantly increasing total shareholders' equity to $39.3 million.
Aptera Motors Corp. reported a net loss of $35.0 million for the nine months ended September 30, 2026, compared to a $28.4 million loss in the prior year period, driven by increased research and development costs. The company remains in the development stage with zero revenue and a total accumulated deficit of $353.7 million as of the reporting date.
DataMEDS AI reported Q3 2026 revenue of $2.7 million, representing 50% sequential growth driven by its Corexa Pharmacy drug dispensing business. The company achieved a net profit of $2.72 per share and regained full compliance with Nasdaq listing standards during the period. Key strategic developments included the launch of the Health Lives Here mobile app and the acquisition of the Helomics cancer diagnostics laboratory.
Term
Q3 2026
“Corexa Pharmacy drove a 50% sequential increase in revenue this quarter with continued growth expected for the fourth quarter based upon the steps we have taken to add additional revenue streams of medical foods and diagnostic lab tests related to patients to whom we dispense prescriptions.”